CPhI Korea 2014 Scheduled for Sept. 2-3 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Korea 2014 Scheduled for Sept. 2-3


CPhI Korea 2014 is scheduled to take place on Sept. 2-3 at the COEX in Seoul, South Korea. Co-organized by the Korean Pharmaceutical Traders Association, the event will co-locate with ICSE, to cover pharmaceutical supply chain sourcing and partnerships.

CPhI Korea and ICSE will provide pharmaceutical manufacturers access to global suppliers across various aspects of the pharmaceutical supply chain, including raw materials, machinery, packaging solutions and contracting services. Conference programs will offer insights from key government, industry, and academic opinion leaders.

UBM Live, the organizer of CPhI Korea, reports the value of the South Korean pharmaceutical market is expected to reach $24.3 billion in 2020 according to a MarketOptimizer.com report. Further solidifying South Korea as one of the largest pharmaceutical markets in Asia, the country’s Pharma 2020 vision is to commit $8.9 billion to drug development by 2020. CPhI Korea will grant key delegates and industry leaders from Japan, China, India and Hong Kong access to this growing market.

Source: CPhI Korea

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here